• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
VIRX

VIRX

Viracta Therapeutics, Inc.

OTCHealthcareBiotechnologyUS

USD0.01

+0.00 (+0.00%)

Company Profile

CEO

Craig R. Jalbert

IPO Date

2005-09-27

Sector

Healthcare

Industry

Biotechnology

Exchange

OTC

Country

US

Market Metrics

Open

$0.01

Prev. Close

$0.01

Day Low

$0.01

Day High

$0.01

52W Low

$0.01

52W High

$0.19

Market Cap

$0.00B

Volume

0.38M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

4

Avg Positive

47.5%

Avg Negative

1.0%

Avg Neutral

51.0%

News Feed

Viracta Therapeutics Announces FDA Clearance of IND Application for Phase 1b/2 Trial in Epstein-Barr Virus-Positive (EBV+) Solid Tumors

PRNewsWire·7/21/2021·↑ positive

Viracta Therapeutics Announces its Addition to the Russell 2000® Index and other FTSE Russell Indexes

PRNewsWire·6/28/2021·↑ positive

Viracta Therapeutics to Host Key Opinion Leader Webinar

PRNewsWire
·5/18/2021
·↑ positive

Viracta Therapeutics Reports First Quarter 2021 Financial Results and Provides Clinical and Corporate Updates

PRNewsWire·5/12/2021·↑ positive